Centre Léon Bérard, Lyon, France.
BMC Cancer. 2010 Apr 19;10:150. doi: 10.1186/1471-2407-10-150.
Sarcomas are rare malignant tumors. Accurate initial histological diagnosis is essential for adequate management. We prospectively assessed the medical management of all patients diagnosed with sarcoma in a European region over a one-year period to identify the quantity of first diagnosis compared to central expert review (CER).
Histological data of all patients diagnosed with sarcoma in Rhone-Alpes between March 2005 and Feb 2006 were collected. Primary diagnoses were systematically compared with second opinion from regional and national experts.
Of 448 patients included, 366 (82%) matched the inclusion criteria and were analyzed. Of these, 199 (54%) had full concordance between primary diagnosis and second opinion (the first pathologist and the expert reached identical conclusions), 97 (27%) had partial concordance (identical diagnosis of conjonctive tumor but different grade or subtype), and 70 (19%) had complete discordance (different histological type or invalidation of the diagnosis of sarcoma). The major discrepancies were related to histological grade (n = 68, 19%), histological type (n = 39, 11%), subtype (n = 17, 5%), and grade plus subtype or grade plus histological type (n = 43, 12%).
Over 45% of first histological diagnoses were modified at second reading, possibly resulting in different treatment decisions. Systematic second expert opinion improves the quality of diagnosis and possibly the management of patients.
肉瘤是罕见的恶性肿瘤。准确的初始组织学诊断对于充分的治疗至关重要。我们前瞻性评估了在一个欧洲地区一年内所有诊断为肉瘤的患者的医学管理,以确定首次诊断的数量与中心专家审查(CER)相比。
收集了 2005 年 3 月至 2006 年 2 月在罗纳-阿尔卑斯地区诊断为肉瘤的所有患者的组织学数据。对首次诊断与区域和国家专家的第二意见进行了系统比较。
448 例患者中,366 例(82%)符合纳入标准并进行了分析。其中,199 例(54%)首次诊断与第二意见完全一致(第一病理学家和专家得出了相同的结论),97 例(27%)部分一致(诊断为结蹄组织肿瘤,但分级或亚型不同),70 例(19%)完全不一致(组织学类型不同或肉瘤诊断无效)。主要差异与组织学分级(n=68,19%)、组织学类型(n=39,11%)、亚型(n=17,5%)以及分级+亚型或分级+组织学类型(n=43,12%)有关。
超过 45%的首次组织学诊断在第二次阅读时被修改,可能导致不同的治疗决策。系统的第二次专家意见可提高诊断质量,并可能改善患者的管理。